Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human GIRK2 ELISA Kit (AC3423)
Cat.#: ASET-2012
Specifications
Description Human GIRK2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human GIRK2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.149 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 3-48 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1849 Mouse PTN ELISA Kit (AC3260) Quantitative inquiry ASET-1945 Human ZnT1 ELISA Kit (AC3356) Quantitative inquiry ASET-1142 Human SHANK3 ELISA Kit (AC2553) Quantitative inquiry ASET-1354 Human Carboxypeptidase E ELISA Kit (AC2765) Quantitative inquiry ASET-1916 Human Lgi4 ELISA Kit (AC3327) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry ASET-1154 Human PEDF ELISA Kit (AC2565) Quantitative inquiry ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-2059 Human CysLT1 ELISA Kit (AC3470) Quantitative inquiry ASET-1494 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2905) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket